Repligen Corp.

Company Snapshot

Founded: 1981
Entity Type: Public
Employees: 1,778
Region: North America
Revenue: $634.4 Millions
Revenue Year: 2024
Headquarter: Massachusetts, U.S.
Key Geographics: North America, Europe, Asia-Pacific, Rest of world
Corporate Address: 41 Seyon Street, Building 1, Suite 100, Waltham, Massachusetts 02453 U.S. Tel. +1-781-250-0111 www.repligen.com

Company Overview

Repligen Corp. is a life sciences company that develops and commercializes bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The majority of the 19 manufacturing sites and assembly centers are located in the U.S., and their primary warehouse and distribution centers are located in Massachusetts and California. The company’s bioprocessing business is comprised of four main segments: filtration (including fluid management), chromatography, process analytics and proteins. The company’s filtration products offer several advantages to manufacturers of biologic drugs and are used in process development and process scale (clinical and commercial) production.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Repligen Corp. In Reports

Pharmaceutical Filtration: Global Markets

BCC Research Market Analyst says global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029 at a CAGR of 9.8%.

Proteomics: Technologies and Global Markets

Global proteomics market should reach $55.1 billion by 2027 from $27.1 billion in 2022 at a CAGR of 15.3% for the forecast period of 2022 to 2027.

Pharmaceutical Filtration: Global Markets

BCC Research Market Report for Pharmaceutical Filtration industry. analysis of the global markets for pharmaceutical filtration market trends, with market revenue and CAGRs through 2027.

Company's Business Segments

  • Product : Upstream Filtration, Downstream Filtration, Chromatography, Fluid Management, Cell Culture Supplements, Ligands, Analytics, Dialysis
  • Royalty and Other Income : Royalty revenues for all periods presented relate to royalties received from a third-party systems manufacturer associated with our OPUS chromatography columns.

Applications/End User Industries

  • Healthcare
  • Biopharmaceutical
  • Research Institutes
  • Life Sciences